INS and Insulin resistance: In addition, SREBP was found to be elevated in animal models with fatty liver and insulin resistance; moreover, despite insulin resistance in peripheral tissues, insulin was still able to activate SREBP in the liver, thus inducing downstream lipogenic enzymes (37, 38).